Department of Ophthalmology and Visual Sciences, Khoo Teck Puat Hospital, Singapore.
Eye (Lond). 2012 Mar;26(3):379-88. doi: 10.1038/eye.2011.218. Epub 2012 Jan 6.
BACKGROUND/AIMS: Utility values of age-related macular degeneration (AMD) in Asian patients are unknown. This study aims to assess utility values and construct validity of the EuroQOL-5D (EQ-5D), time trade-off (TTO), and standard gamble (SG) instruments in the Singapore multi-ethnic AMD population.
Cross-sectional, two-centre, institution-based study. Visual acuity (VA), clinical AMD severity, and utility scores on the EQ-5D, TTO, and SG were obtained from 338 AMD patients. VA was analysed in terms of the better-seeing eye (BEVA), worse-seeing eye (WEVA), and weighted average of both eyes (WVA). We evaluated SG on the perfect health-death (SG(death)) and binocular perfect vision-binocular blindness (SG(blindness)) scales. Construct validity was determined by testing a priorihypotheses relating the EQ-5D, TTO, and SG utility scores to VA and clinical AMD severity.
The mean utilities on the EQ-5D, TTO, SG(death), and SG(blindness) were 0.89, 0.81, 0.86, and 0.90, respectively. EQ-5D scores correlated weakly with BEVA, WEVA, and WVA (Pearson's correlation coefficients -0.291, -0.247, and -0.305 respectively, P<0.001 for all). SG(death) and SG(blindness) demonstrated no correlation with BEVA, WEVA, or WVA (Pearson's correlation coefficients, range -0.06 to -0.125). TTO showed weak association only with WEVA and WVA (correlation coefficients -0.237, -0.228, P<0.0001), but not with BEVA (correlation coefficient -0.161). Clinical AMD severity correlated with EQ-5D and SG(death), but not with TTO and SG(blindness) (P=0.004, 0.002, 0.235, and 0.069, respectively).
AMD has a negative impact on utilities, although utility scores were high compared with Western cohorts. EQ-5D, TTO, and SG showed suboptimal construct validity, suggesting that health status utilities may not be sufficiently robust for cost-utility analyses in this population.
背景/目的:年龄相关性黄斑变性(AMD)在亚洲患者中的效用值尚不清楚。本研究旨在评估新加坡多民族 AMD 人群中欧洲五维健康量表(EQ-5D)、时间权衡(TTO)和标准博弈(SG)工具的效用值和结构效度。
横断面、双中心、机构基础研究。从 338 名 AMD 患者中获得视力(VA)、临床 AMD 严重程度和 EQ-5D、TTO 和 SG 的效用评分。VA 以较好眼(BEVA)、较差眼(WEVA)和双眼加权平均值(WVA)进行分析。我们在完美健康-死亡(SG(死亡))和双眼完美视力-双眼盲目(SG(盲目))量表上评估了 SG。结构效度通过测试与 VA 和临床 AMD 严重程度相关的先验假设来确定。
EQ-5D、TTO、SG(死亡)和 SG(盲目)的平均效用值分别为 0.89、0.81、0.86 和 0.90。EQ-5D 评分与 BEVA、WEVA 和 WVA 呈弱相关(Pearson 相关系数分别为-0.291、-0.247 和-0.305,均<0.001)。SG(死亡)和 SG(盲目)与 BEVA、WEVA 或 WVA 无相关性(Pearson 相关系数范围为-0.06 至-0.125)。TTO 仅与 WEVA 和 WVA 呈弱相关性(相关系数-0.237、-0.228,P<0.0001),但与 BEVA 无关(相关系数-0.161)。临床 AMD 严重程度与 EQ-5D 和 SG(死亡)相关,但与 TTO 和 SG(盲目)无关(P=0.004、0.002、0.235 和 0.069)。
AMD 对效用值有负面影响,尽管与西方队列相比,效用值较高。EQ-5D、TTO 和 SG 显示出结构效度不佳,表明在该人群中,健康状况效用值可能不足以进行成本效用分析。